CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a...
from NDTV News - Special https://ift.tt/HAad5FK
Subscribe to:
Post Comments (Atom)
Popular Posts
-
By BY THE NEW YORK TIMES from NYT U.S. https://ift.tt/2JDppgp
-
By ELLEN GABLER from NYT U.S. https://nyti.ms/2KefSxQ
-
Tigress Arrowhead (T-84), one of Ranthambore's most celebrated big cats, passed away at the age of 14, forest officials confirmed on Thu...
Covaxin Maker Gets $19 Million For Development Of 'Variant Proof' Vaccine
CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a...
from NDTV News - Special https://ift.tt/HAad5FK
from NDTV News - Special https://ift.tt/HAad5FK
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment